Novo CEO pressed by Senate to cut rates of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen explained to lawmakers the corporation would take into consideration new talks with insurers regarding the list selling prices of Wegovy and copyright if they pledge to maintain the medicines on their own formularies. https://dave-s-hot-chicken-calori16050.activoblog.com/31757509/everything-about-healthcare-news